Form D Explorer

Form C-U — AlphaRose Therapeutics Inc

0002051498-25-000002 · filed 2025-10-06 · via StartEngine Primary, LLC

Offering

Target: $19,998
Maximum: $4,999,999
Security type: Common Stock
Price per security: $1.3500
Deadline: —
Oversubscription: Accepted

Issuer

Name: AlphaRose Therapeutics Inc
CIK: 2051498
Entity: Corporation
Jurisdiction: DE
Address: 1401 LAVACA STREET, #851
AUSTIN, TX 78701
Phone: —

Most recent fiscal year financials

Total assets

$614,498

Cash

—

Short-term debt

$81,098

Long-term debt

$1,151,098

Revenues

—

COGS

—

Taxes paid

—

Net income

$-625,253

View original on SEC EDGAR.